Richard Wooster - 21 Jan 2022 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Douglas R. Carlson, as Attorney-in-Fact for Richard Wooster
Issuer symbol
IKNA
Transactions as of
21 Jan 2022
Net transactions value
$0
Form type
4
Filing time
25 Jan 2022, 20:34:39 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +29,200 $0.000000 29,200 21 Jan 2022 Common Stock 29,200 $11.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in equal installments on the first, second, and third anniversaries of the grant date.